BSAC or TD: Which Is the Better Value Stock Right Now?
https://www.zacks.com/stock/news/2260404/bsac-or-td-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2260404
Apr 23, 2024 - BSAC vs. TD: Which Stock Is the Better Value Option?
0
TD Cowen says sickle cell therapies may get higher CMS payments
https://seekingalpha.com/news/4089805-td-cowen-says-sickle-cell-therapies-may-get-higher-cms-payments?source=feed_sector_healthcare
Apr 15, 2024 - TD Cowen said recently approved gene therapies by Vertex (VRTX)/CRISPR (CRSP) and bluebird bio (BLUE) may get enhanced payments under proposed CMS guidelines. Read more here.
0
Why TD SYNNEX (SNX) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2250469/why-td-synnex-snx-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2250469
Apr 04, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
TD Bank: Now Is A Good Time To Buy This 5%-Yielding Blue-Chip Deal
https://seekingalpha.com/article/4681247-td-bank-good-time-to-buy-5-percent-yielding-blue-chip-deal?source=feed_all_articles
Mar 29, 2024 - TD Bank's financial position is vigorous enough to earn upper investment-grade credit ratings from the three major rating agencies. Read why I rate TD stock a buy.
0
TD Bank (TD) Rolls Out TD Complete Checking & TD Early Pay
https://www.zacks.com/stock/news/2246889/td-bank-td-rolls-out-td-complete-checking-td-early-pay?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2246889
Mar 27, 2024 - TD Bank's (TD) TD Complete Checking and TD Early Pay offerings are set to offer customers convenience and help the company enhance its deposit balance.
0
TD Cowen ups Stoke to buy on updated data for epilepsy drug
https://seekingalpha.com/news/4083718-td-cowen-ups-stoke-to-buy-on-updated-data-for-epilepsy-drug?source=feed_sector_healthcare
Mar 26, 2024 - TD Cowen upgraded Stoke Therapeutics (STOK) to buy based on updated Phase 1/2 data for the company’s epilepsy drug candidate STK-001. Read more here.
0
Compared to Estimates, TD SYNNEX (SNX) Q1 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2246078/compared-to-estimates-td-synnex-snx-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2246078
Mar 26, 2024 - Although the revenue and EPS for TD SYNNEX (SNX) give a sense of how its business performed in the quarter ended February 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
TD Cowen cuts Immuneering to market perform, cites Phase 1 data
https://seekingalpha.com/news/4080047-td-cowen-cuts-immuneering-to-market-perform-cites-phase-1-data?source=feed_sector_healthcare
Mar 15, 2024 - TD Cowen has downgraded Immuneering (IMRX) to market perform, citing disappointing data from the company’s Phase 1 study for IMM-1-104 in treating solid tumors. Read more here.
0
Analysts Estimate Toronto-Dominion Bank (TD) to Report a Decline in Earnings: What to Look Out for
https://www.zacks.com/stock/news/2230242/analysts-estimate-toronto-dominion-bank-td-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2230242
Feb 22, 2024 - Toronto-Dominion (TD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Telephone and Data Systems, Inc. (TDS) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4671101-telephone-and-data-systems-inc-tds-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Feb 16, 2024 - Telephone and Data Systems, Inc. (NYSE:NYSE:TDS) Q4 2023 Earnings Conference Call February 16, 2024 10:00 AM ETCompany ParticipantsColleen Thompson - VP,...
0
Pages: 12
Page 1